Financing, Equity Capital Markets

CRISPR Therapeutics AG

11/19
|
$315.2 Million
Piper Sandler served as bookrunnerfor CRISPR Therapeutics AG on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma